Dr. RUHI GUNAY

Dr. MEHUL SHAH, Dr. SHREYA SHAH, Dr. DEEKSHA THORAT

Abstract

INTRODUCTION: BRVO IS AN IMPORTANT CAUSE OF MONOCULAR VISION LOSS, FOR WHICH WE WOULD LIKE TO DO COMPARATIVE STUDY OF ZYBEV AND AVASTIN ON CMT

METHOD: THIS IS A RETROSPECTIVE ANALYSIS OF A COHORT DURING LAST FIVE YEARS AT TERTIARY EYE CARE CENTER. ALL EYES WERE TREATED WITH MEDICAL AND LASER THERAPY. CREATION OF FORMAT AND RETRIEVAL OF DATA FROM EMR AND ANALYSED WITH SPSS 22. DESCRIPTIVE AND CROSS TABULATION METHOD USED FOR ANALYSES. P VALUE <0.05 CONSIDERED STASTICALLY SIGNIFICANT. RESULT: COHORT CONSISTED OF 155 EYES OF 152 PATIENTS. 53.3%,46.7% M:F,MEAN AGE 57.4 YEARS. ON PRESENTATION 33.7% HAD VISION >6/24 AND 41.1 % HAD VISION < 3/60. POST TREATMENT VISION ON SUBSEQUENT VISITS >6/24 IN 32.5% AND <3/60 IN 21.8% CASES. WHEN WE COMPARED CMT AMONGST AVASTIN AND ZYBEV GROUP,NO SIGNIFICANT DIFFERENCE WAS FOUND (P=0.54). CONCLUSION: NO SIGNIFICANT DIFFERENCE ON CMT BETWEEN AVASTIN AND ZYBEV TREATED PATIENTS FOLLOWING MANAGEMENT OF BRVO.[advanced_iframe src="https://view.officeapps.live.com/op/embed.aspx?src=https://aiosproceedings.s3.ap-southeast-1.amazonaws.com/2021/E-Poster/FP329.pptx" width="100%" height="608"]